LPA receptors: subtypes and biological actions - PubMed (original) (raw)
Review
LPA receptors: subtypes and biological actions
Ji Woong Choi et al. Annu Rev Pharmacol Toxicol. 2010.
Abstract
Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling molecule by binding to and activating at least five known G protein-coupled receptors (GPCRs): LPA(1)-LPA(5). They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice. The biological roles of LPA are diverse and include developmental, physiological, and pathophysiological effects. This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors. Studies using cloned receptors and genetic knockout mice have been instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ systems such as the nervous system. This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.
Similar articles
- Lysophosphatidic acid (LPA) and its receptors.
Noguchi K, Herr D, Mutoh T, Chun J. Noguchi K, et al. Curr Opin Pharmacol. 2009 Feb;9(1):15-23. doi: 10.1016/j.coph.2008.11.010. Epub 2008 Dec 30. Curr Opin Pharmacol. 2009. PMID: 19119080 Review. - LPA receptor signaling: pharmacology, physiology, and pathophysiology.
Yung YC, Stoddard NC, Chun J. Yung YC, et al. J Lipid Res. 2014 Jul;55(7):1192-214. doi: 10.1194/jlr.R046458. Epub 2014 Mar 18. J Lipid Res. 2014. PMID: 24643338 Free PMC article. Review. - Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
Meduri B, Pujar GV, Durai Ananda Kumar T, Akshatha HS, Sethu AK, Singh M, Kanagarla A, Mathew B. Meduri B, et al. Eur J Med Chem. 2021 Oct 15;222:113574. doi: 10.1016/j.ejmech.2021.113574. Epub 2021 Jun 2. Eur J Med Chem. 2021. PMID: 34126459 Review. - Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.
Lin ME, Herr DR, Chun J. Lin ME, et al. Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):130-8. doi: 10.1016/j.prostaglandins.2009.02.002. Epub 2009 Mar 4. Prostaglandins Other Lipid Mediat. 2010. PMID: 20331961 Free PMC article. Review. - LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
Hama K, Aoki J. Hama K, et al. Prog Lipid Res. 2010 Oct;49(4):335-42. doi: 10.1016/j.plipres.2010.03.001. Epub 2010 Mar 15. Prog Lipid Res. 2010. PMID: 20230855 Review.
Cited by
- Lysophospholipid mediators in the vasculature.
Mueller P, Ye S, Morris A, Smyth SS. Mueller P, et al. Exp Cell Res. 2015 May 1;333(2):190-194. doi: 10.1016/j.yexcr.2015.03.016. Epub 2015 Mar 28. Exp Cell Res. 2015. PMID: 25825155 Free PMC article. Review. - Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis.
Fransson J, Gómez-Conde AI, Romero-Imbroda J, Fernández O, Leyva L, de Fonseca FR, Chun J, Louapre C, Van-Evercooren AB, Zujovic V, Estivill-Torrús G, García-Díaz B. Fransson J, et al. Mol Neurobiol. 2021 Feb;58(2):470-482. doi: 10.1007/s12035-020-02130-x. Epub 2020 Sep 24. Mol Neurobiol. 2021. PMID: 32974731 - Structure of the active Gi-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist.
Akasaka H, Tanaka T, Sano FK, Matsuzaki Y, Shihoya W, Nureki O. Akasaka H, et al. Nat Commun. 2022 Sep 15;13(1):5417. doi: 10.1038/s41467-022-33121-2. Nat Commun. 2022. PMID: 36109516 Free PMC article. - Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder.
Requena-Ocaña N, Flores-López M, García-Marchena N, Pavón-Morón FJ, Pedraza C, Wallace A, Castilla-Ortega E, Rodríguez de Fonseca F, Serrano A, Araos P. Requena-Ocaña N, et al. Int J Mol Sci. 2023 Oct 25;24(21):15586. doi: 10.3390/ijms242115586. Int J Mol Sci. 2023. PMID: 37958570 Free PMC article. - Lysophosphatidic Acid Receptors LPAR5 and LPAR2 Inversely Control Hydroxychloroquine-Evoked Itch and Scratching in Mice.
Fischer C, Schreiber Y, Nitsch R, Vogt J, Thomas D, Geisslinger G, Tegeder I. Fischer C, et al. Int J Mol Sci. 2024 Jul 26;25(15):8177. doi: 10.3390/ijms25158177. Int J Mol Sci. 2024. PMID: 39125747 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS048478/NS/NINDS NIH HHS/United States
- UL1 RR025774/RR/NCRR NIH HHS/United States
- R01 MH051699/MH/NIMH NIH HHS/United States
- NS048478/NS/NINDS NIH HHS/United States
- MH051699/MH/NIMH NIH HHS/United States
- HD050685/HD/NICHD NIH HHS/United States
- R01 DA019674/DA/NIDA NIH HHS/United States
- R01 HD050685/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous